Log in

Relevant bibliographies by topics / Clinical factors / Journal articles

To see the other types of publications on this topic, follow the link: Clinical factors.

Journal articles on the topic 'Clinical factors'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Clinical factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

BS, Lakshmi. "Abruptio Placentae – Risk Factors and Clinical Manifestations." Journal of Medical Science And clinical Research 05, no. 01 (January 18, 2017): 15722–27. http://dx.doi.org/10.18535/jmscr/v5i1.82.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Köhne, Claus-Henning, Udo Vanhoefer, and Gernot Hartung. "Clinical predictive factors." European Journal of Cancer 45 (September 2009): 43–49. http://dx.doi.org/10.1016/s0959-8049(09)70015-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Jain, Mayank. "Myocardial Infarction in “Women”: Clinical Profile and Risk Factors." Journal of Cardiovascular Medicine and Surgery 4, no. 3 (2018): 221–24. http://dx.doi.org/10.21088/jcms.2454.7123.4318.5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

S, Kannan, and Gowri S. "Motivating factors for recruitment of children in clinical trials." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 04, no. 3 (September 15, 2014): 313–15. http://dx.doi.org/10.58739/jcbs/v04i3.6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ingegnoli, Francesca, Roberto Castelli, and Roberta Gualtierotti. "Rheumatoid Factors: Clinical Applications." Disease Markers 35 (2013): 727–34. http://dx.doi.org/10.1155/2013/726598.

Full text

Abstract:

Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part of the workup for the differential diagnosis of arthropathies. In clinical practice, it is recommended to measure anti-cyclic citrullinated peptide antibodies and rheumatoid factors together because anti-cyclic citrullinated peptide antibodies alone are only moderately sensitive, and the combination of the two markers improves diagnostic accuracy, especially in the case of early rheumatoid arthritis. Furthermore, different rheumatoid factor isotypes alone or in combination can be helpful when managing rheumatoid arthritis patients, from the time of diagnosis until deciding on the choice of therapeutic strategy.

APA, Harvard, Vancouver, ISO, and other styles

6

Heath, David A. "Primary Hyperparathyroidism: Clinicai Presentation and Factors Influencing Clinical Management." Endocrinology and Metabolism Clinics of North America 18, no. 3 (September 1989): 631–46. http://dx.doi.org/10.1016/s0889-8529(18)30357-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nuray Sever, Özlem, Gökmen Aktaş, Başar Aksoy, and Mustafa Yıldırım. "CLINICAL FACTORS PREDICTING RESPONSE TO REGORAFENIB IN METASTATIC COLORECTAL CANCER." Euroasia Journal of Mathematics, Engineering, Natural & Medical Sciences 9, no. 20 (March 25, 2022): 23–27. http://dx.doi.org/10.38065/euroasiaorg.924.

Full text

Abstract:

Colorectal cancer (CRC) is a common disease with high mortality. Regorafenib (Stivarga ®) is an oral small molecule, multiple kinase inhibitor approved worldwide for use in metastatic colorectal cancer. In our study, clinical factors predicting response to regorafenib were investigated. Patients who applied to Gaziantep Medical Park Hospital and Sanko University Medical Faculty Hospital Medical Oncology outpatient clinic between 2010-2021 with the diagnosis of mCRC and using regorafenib were included in the study. Electronic medical records of the patients were reviewed retrospectively. Statistical analyzes were performed using SPSS version 15.0 software. A total of 20 patients with metastatic colorectal cancer using regorafenib in the third or fourth line therapy were included in the study. Overall, 15 (75%) patients had liver metastases. The median overall survival of the patients was 25.5 months (95% Confidence Interval (CI), 24.1-26.8). Overall survival was not significantly associated with sex, ECOG performance status score, de novo metastatic disease status, smoking status and weight loss history (p=0.139, p=0.240, p=0.173, p=0.911, p=0.923, respectively). A significant association was found between the presence of liver metastasis and survival (p=0.036). The median overall survival was 40.3 months (95% CI, 0-92.6) in patients without liver metastases, and 25 months (95% CI: 13.8-36.2) in patients with liver metastases. In this retrospective study investigating the factors affecting the survival of patients using regorafenib with the diagnosis of mCRC, the presence of liver metastasis was found to be associated with a poor prognosis.

APA, Harvard, Vancouver, ISO, and other styles

8

Kutsal, Yeşim Gökçe. "The Frequency of the Clinical Risk Factors in Postmenopausal Osteoporosis." Turkish Journal of Rheumatology 28, no. 4 (December 13, 2013): 256–62. http://dx.doi.org/10.5606/tjr.2013.3336.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Walinjkar, Manjiri. "Clinical study to evaluate the causative factors of Shvitra (Vitiligo)." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 2, no. 5 (January 25, 2017): 130–34. http://dx.doi.org/10.21276/jrtm.2016/304.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Guedes, Nirla Gomes, Marcos Venícios de Oliveira Lopes, Viviane Martins da Silva, Lara Jales Rodrigues Farias, Leonardo Alexandrino da Silva, and Cristina Costa Bessa. "Clinical validation of factors associated with sedentary lifestyle in adolescents." Rev Rene 20 (May 16, 2019): e40395. http://dx.doi.org/10.15253/2175-6783.20192040395.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bajpai, Dr Shikhar. "A Clinical Study of Risk Factors of Coronary Artery Disease including newer Risk Factors in Elderly Patients." Journal of Medical Science And clinical Research 05, no. 01 (January 13, 2017): 15499–507. http://dx.doi.org/10.18535/jmscr/v5i1.50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Suto, Daniel J., Emily Perrinez, Karen S. Rapp, Mohammed Nabulsi, and Thomas M. Hemmen. "Clinical and Demographic Factors Influence Clinical Trial Enrollment." Journal of Stroke and Cerebrovascular Diseases 30, no. 6 (June 2021): 105771. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.105771.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Jadhav AK, Jadhav AK, Mulla NH Mulla NH, Prasad HB Prasad HB, and Kadam DB Kadam DB. "Study of Clinical Course and Prognostic Factors Affecting Course of Septicemia." International Journal of Scientific Research 3, no. 2 (June 1, 2012): 397–99. http://dx.doi.org/10.15373/22778179/feb2014/130.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

H S, Nethra, Praneetha K, Sreelatha S, and Seema Shyam Bhairi. "A study on risk factors and clinical presentation of ectopic pregnancy." New Indian Journal of OBGYN 4, no. 2 (January 2018): 146–49. http://dx.doi.org/10.21276/obgyn.2018.4.2.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Takaku, Fumimaro. "Clinical use of hematopoietic factors." SEIBUTSU BUTSURI KAGAKU 33, no. 1 (1989): 17–20. http://dx.doi.org/10.2198/sbk.33.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Casa, Douglas J. "Clinical and Practical Risk Factors." Medicine & Science in Sports & Exercise 37, Supplement (May 2005): S335. http://dx.doi.org/10.1249/00005768-200505001-01731.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Casa, Douglas J. "Clinical and Practical Risk Factors." Medicine & Science in Sports & Exercise 37, Supplement (May 2005): S335. http://dx.doi.org/10.1097/00005768-200505001-01731.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bronchud, M. H., and T. M. Dexter. "Clinical use of growth factors." British Medical Bulletin 45, no. 2 (1989): 590–99. http://dx.doi.org/10.1093/oxfordjournals.bmb.a072345.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sveinsson, Olafur, Tomas Andersson, Peter Mattsson, Sofia Carlsson, and Torbjörn Tomson. "Clinical risk factors in SUDEP." Neurology 94, no. 4 (December 12, 2019): e419-e429. http://dx.doi.org/10.1212/wnl.0000000000008741.

Full text

Abstract:

ObjectiveWe conducted a nationwide case-control study in Sweden to test the hypothesis that specific clinical characteristics are associated with increased risk of sudden unexpected death in epilepsy (SUDEP).MethodsThe study included 255 SUDEP cases (definite and probable) and 1,148 matched controls. Clinical information was obtained from medical records and the National Patient Register. The association between SUDEP and potential risk factors was assessed by odds ratios (ORs) and 95% confidence intervals (CIs) and interaction assessed by attributable proportion due to interaction (AP).ResultsExperiencing generalized tonic-clonic seizures (GTCS) during the preceding year was associated with a 27-fold increased risk (OR 26.81, 95% CI 14.86–48.38), whereas no excess risk was seen in those with exclusively non-GTCS seizures (OR 1.15, 95% CI 0.54–48.38). The presence of nocturnal GTCS during the last year of observation was associated with a 15-fold risk (OR 15.31, 95% CI 9.57–24.47). Living alone was associated with a 5-fold increased risk of SUDEP (OR 5.01, 95% CI 2.93–8.57) and interaction analysis showed that the combination of not sharing a bedroom and having GTCS conferred an OR of 67.10 (95% CI 29.66–151.88), with AP estimated at 0.69 (CI 0.53–0.85). Among comorbid diseases, a previous diagnosis of substance abuse or alcohol dependence was associated with excess risk of SUDEP.ConclusionsIndividuals with GTCS who sleep alone have a dramatically increased SUDEP risk. Our results indicate that 69% of SUDEP cases in patients who have GTCS and live alone could be prevented if the patients were not unattended at night or were free from GTCS.

APA, Harvard, Vancouver, ISO, and other styles

20

Bean, John W. "FACTORS INFLUENCING CLINICAL OXYGEN TOXICITY." Annals of the New York Academy of Sciences 117, no. 2 (March 14, 2007): 745–55. http://dx.doi.org/10.1111/j.1749-6632.1964.tb56323.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

WICK, BRUCE. "Clinical Factors in Proximal Vergence." Optometry and Vision Science 62, no. 1 (January 1985): 1–18. http://dx.doi.org/10.1097/00006324-198501000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Davis, Ian, and George Morstyn. "Clinical uses of growth factors." Baillière's Clinical Haematology 5, no. 3 (July 1992): 753–86. http://dx.doi.org/10.1016/s0950-3536(11)80016-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Jiang, Zhu-Ming, Douglas W. Wilmore, Wei Liu, and Yue-Wu Liu. "Growth Factors in Clinical Practice." World Journal of Surgery 24, no. 12 (December 2000): 1514–18. http://dx.doi.org/10.1007/s002680010270.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Westermeyer, Joseph. "Cultural factors in clinical assessment." Journal of Consulting and Clinical Psychology 55, no. 4 (1987): 471–78. http://dx.doi.org/10.1037/0022-006x.55.4.471.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dahlberg, Steve, and Ping-Yu Liu. "Prognostic factors in clinical trials." Breast Cancer Research and Treatment 22, no. 3 (October 1992): 193–96. http://dx.doi.org/10.1007/bf01840832.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Riggs, J. E. "Clinical Applications of Neurotrophic Factors." Archives of Neurology 55, no. 4 (April 1, 1998): 575. http://dx.doi.org/10.1001/archneur.55.4.575.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Gaugler-Senden, Ingrid P. M., Eva M. Roes, Christianne J. M. de Groot, and Eric A. P. Steegers. "Clinical risk factors for preeclampsia." European Clinics in Obstetrics and Gynaecology 1, no. 1 (February 22, 2005): 36–50. http://dx.doi.org/10.1007/s11296-004-0010-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Köveker, GB. "GROWTH FACTORS IN CLINICAL PRACTICE." International Journal of Clinical Practice 54, no. 9 (November 2000): 590–93. http://dx.doi.org/10.1111/j.1742-1241.2000.tb10933.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Sujata, P. "A Retrospective Study on Risk Factors and Clinical Presentation of Ectopic Pregnancy." Journal of Medical Science And clinical Research 05, no. 01 (January 24, 2017): 15983–88. http://dx.doi.org/10.18535/jmscr/v5i1.122.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

AS Raghuram, Ramanathan R,. "Etiological Factors, Clinical Profile and Outcome of Meconium Aspiration Syndrome in Newborn." Journal of Medical Science And clinical Research 05, no. 05 (May 6, 2017): 21509–14. http://dx.doi.org/10.18535/jmscr/v5i5.47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

KOBYS, TATIANA. "PROGNOSTIC VALUE OF CLINICAL AND NEUROIMAGING RISK FACTORS OF MULTIPLE SCLEROSIS ACTIVITY." Bulletin of Contemporary Clinical Medicine 9, no. 3 (June 2016): 12–18. http://dx.doi.org/10.20969/vskm.2016.9(3).12-18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Hafeez, Resham, Hina Mahmood, Fahad Raza, Wajeeha Jabeen, and Pakiza Raza Hyder. "Factors Influencing the Emergence of Antimicrobial Drug Resistance in Clinical Dental Practice." Journal of the Pakistan Dental Association 32, no. 02 (September 27, 2023): 60–65. http://dx.doi.org/10.25301/jpda.322.60.

Full text

Abstract:

OBJECTIVE: To investigate the perception of general dentists regarding the over-prescription of antibiotics leading to Antimicrobial drug resistance in their clinical practice. METHODOLOGY: A cross-sectional study encompassing a personalized Likert scale questionnaire on factors influencing anti-microbial resistance in dental general practices was conducted on 196 practitioners. The questionnaire inquired about different factors which tend to affect the over-prescription of antibiotics and influence anti-microbial resistance. It was piloted on 30 participants before dissemination. RESULTS: Factors showing the highest level of agreement were "lack of patient awareness regarding use of antibiotics" (96.9%), "over-the-counter availability" (95.4%), and self-medication" (95.4%). General dental practitioners were overprescribing in their clinical setup due to improper guidelines (24.4%), for their patient's satisfaction (21.2%), and lack of knowledge (19.2%).33.5% of them stated that patients reporting to them were self-medicating and 27.2% found that their patients had a lack of awareness. CONCLUSIONS: This study concluded that all the factors were responsible for the Antimicrobial Drug Resistance phenomenon in clinical dental practice. However, the majority of the dentists were over-prescribing antibiotics due to improper guidelines, lack of knowledge, and for the patient's satisfaction. KEYWORDS: Antimicrobial Drug Resistance; Awareness; Antibiotics; Dental General Practices; Over-the-Counter Drugs.

APA, Harvard, Vancouver, ISO, and other styles

33

Saba, Pier Sergio, Guido Parodi, and Antonello Ganau. "From Risk Factors to Clinical Disease." Journal of the American College of Cardiology 77, no. 11 (March 2021): 1436–38. http://dx.doi.org/10.1016/j.jacc.2021.01.040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

KARIM F. ABD ELMOATY, M.D., ASHRAF A. MOSTAFA, M. D. ;., and MINA A. WILLIAM, M.Sc. "Clinical Prognostic Factors in Breast Cancer." Medical Journal of Cairo University 89, no. 3 (March 1, 2021): 35–45. http://dx.doi.org/10.21608/mjcu.2021.152008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Porcelli, Stefano, Oriana Bianchini, Giovanni De Girolamo, Eugenio Aguglia, Luciana Crea, and Alessandro Serretti. "Clinical factors related to schizophrenia relapse." International Journal of Psychiatry in Clinical Practice 20, no. 2 (April 2, 2016): 54–69. http://dx.doi.org/10.3109/13651501.2016.1149195.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Baddley, John W. "Clinical risk factors for invasive aspergillosis." Medical Mycology 49, S1 (April 2011): S7—S12. http://dx.doi.org/10.3109/13693786.2010.505204.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

NAWADA, SHIN. "Clinical practices for transcriptional control factors." Nihon Naika Gakkai Zasshi 87 (1998): 81–85. http://dx.doi.org/10.2169/naika.87.supplement_81.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Diédhiou, D., D. Sow, M. M. Lèye, I. M. Diallo, M. Bodian, M. A. Ndoure, E. Bouary, M. Ndour Mbaye, A. Sarr, and S. N. Diop. "Cardiothyreosis: Risk Factors and Clinical Profile." Open Journal of Internal Medicine 07, no. 01 (2017): 1–11. http://dx.doi.org/10.4236/ojim.2017.71001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ganser, Arnold, and Meinolf Karthaus. "Clinical use of hematopoietic growth factors." Current Opinion in ONCOLOGY 8, no. 4 (July 1996): 265–69. http://dx.doi.org/10.1097/00001622-199607000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Roth, Lee, Linda McCarthy, and Jamie Gregor. "Predicting Endoscopy Length Using Clinical Factors." American Journal of Gastroenterology 106 (October 2011): S516—S517. http://dx.doi.org/10.14309/00000434-201110002-01349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Khwaja, Asim, and David C. Linch. "Clinical Applications of Haemopoietic Growth Factors." Leukemia & Lymphoma 7, sup1 (January 1992): 69–72. http://dx.doi.org/10.3109/10428199209061569.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Moon, Seong-Hwan, Hak-Sun Kim, and Hwan-Mo Lee. "Growth Factors and Their Clinical Applications." Journal of Korean Society of Spine Surgery 8, no. 3 (2001): 372. http://dx.doi.org/10.4184/jkss.2001.8.3.372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Wilson, Kenneth C. M., and John R. M. Copeland. "Epidemiology, risk factors and clinical features." Current Opinion in Psychiatry 3, no. 4 (August 1990): 516–21. http://dx.doi.org/10.1097/00001504-199008000-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Wilson, Kenneth C. M. "Epidemiology, risk factors and clinical features." Current Opinion in Psychiatry 4, no. 4 (August 1991): 587–90. http://dx.doi.org/10.1097/00001504-199108000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rajasekhar, Praveen T., Colin J. Rees, Catherine Nixon, James E. East, and Sally Brown. "Factors influencing change in clinical practice." International Journal of Health Care Quality Assurance 29, no. 1 (February 8, 2016): 5–15. http://dx.doi.org/10.1108/ijhcqa-09-2014-0093.

Full text

Abstract:

Purpose – The quality improvement in colonoscopy study was a region wide service improvement study to improve adenoma detection rate at colonoscopy by implementing evidence into routine colonoscopy practice. Implementing evidence into clinical practice can be challenging. The purpose of this paper is to perform a qualitative interview study to evaluate factors that influenced implementation within the study. Design/methodology/approach – Semi-structured interviews were conducted with staff in endoscopy units taking part in the quality improvement in colonoscopy study, after study completion. Units and interviewees were purposefully sampled to ensure a range of experiences was represented. Interviews were conducted with 11 participants. Findings – Key themes influencing uptake of the quality improvement in colonoscopy evidence bundle included time, study promotion, training, engagement, positive outcomes and modifications. Areas within themes were increased awareness of quality in colonoscopy (QIC), emphasis on withdrawal time and empowerment of endoscopy nurses to encourage the use of quality measures were positive outcomes of the study. The simple, visible study posters were reported as useful in aiding study promotion. Feedback sessions improved engagement. Challenges included difficulty arranging set-up meetings and engaging certain speciality groups. Originality/value – This evaluation suggests that methods to implement evidence into clinical practice should include identification and empowerment of team members who can positively influence engagement, simple, visible reminders and feedback. Emphasis on timing of meetings and strategies to engage speciality groups should also be given consideration. Qualitative evaluations can provide important insights into why quality improvement initiatives are successful or not, across different sites.

APA, Harvard, Vancouver, ISO, and other styles

46

Clark, Shannon, and P. E. ,. Denise Forkey. "Clinical Actual Use Human Factors Testing." Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care 7, no. 1 (June 2018): 152–54. http://dx.doi.org/10.1177/2327857918071039.

Full text

Abstract:

Due to perceived cost and time savings, medical device and combination product manufacturers frequently consider the option to combine human factors testing with clinical studies. There are some scenarios in which human factors and clinical testing of medical products can be combined to save time and resources. While guidance documents published by the Food and Drug Administration (FDA) emphasize that most human factors validation testing can fully evaluate use-related safety via simulated use usability testing, there are some cases in which clinical actual use usability testing is needed to fully evaluate use-related safety. This paper suggests synergies between clinical testing and human factors testing, presents challenges faced by human factors practitioners when the two types of testing are combined, and offers best practice recommendations to maximize the chance of successfully evaluating the human factors endpoints.

APA, Harvard, Vancouver, ISO, and other styles

47

Foster, Michael. "Peptide Growth Factors: A Clinical Precis." Seminars in Reproductive Medicine 6, no. 01 (February 1988): 29–34. http://dx.doi.org/10.1055/s-2007-1021338.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Brugger, W., E. M. Rosenthal, L. Kanz, and R. Mertelsmann. "Clinical Role of Colony Stimulating Factors." Acta Haematologica 86, no. 3 (1991): 138–47. http://dx.doi.org/10.1159/000204823.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Scarffe, JH. "Hematopoietic Growth Factors in Clinical Applications." British Journal of Cancer 66, no. 2 (August 1992): 415. http://dx.doi.org/10.1038/bjc.1992.282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Trounce, J. Q., D. E. Shaw, M. I. Levene, and N. Rutter. "Clinical risk factors and periventricular leucomalacia." Archives of Disease in Childhood 63, no. 1 (January 1, 1988): 17–22. http://dx.doi.org/10.1136/adc.63.1.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!